Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Longmu Ningxin Formula vs Western medication in pediatric ADHD
ChiCTR2200061786Phase 4Not yet recruiting
- Sponsor
- Longhua Hospital Shanghai University of Traditional Chinese Medicine
- Start
- Jul 2022
- Countries
- 1
01
Overview
Phase 4 trial of longmu ningxin formula in attention deficit hyperactivity disorder (ADHD) (2 arms), sponsored by Longhua Hospital Shanghai University of Traditional Chinese Medicine. Primary endpoints: SNAP-IV questionnaire score, Conners questionnaire score and 2 more. Planned start Jul 2022; status: not yet recruiting.
02
Drugs
longmu ningxin formula
03
Conditions
attention deficit hyperactivity disorder (ADHD)
Beyond the preview
Go deeper on ChiCTR2200061786.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ChiCTR2200061786.